This report serves to describe the mutational landscape and properties of a given individual set, as well as rank genes and genesets according to mutational significance. MutSig 2CV v3.1 was used to generate the results found in this report.
-
Working with individual set: COAD-TP
-
Number of patients in set: 367
The input for this pipeline is a set of individuals with the following files associated for each:
-
An annotated .maf file describing the mutations called for the respective individual, and their properties.
-
A .wig file that contains information about the coverage of the sample.
-
MAF used for this analysis:COAD-TP.final_analysis_set.maf
-
Blacklist used for this analysis: pancan_mutation_blacklist.v14.hg19.txt
-
Significantly mutated genes (q ≤ 0.1): 1354
The mutation spectrum is depicted in the lego plots below in which the 96 possible mutation types are subdivided into six large blocks, color-coded to reflect the base substitution type. Each large block is further subdivided into the 16 possible pairs of 5' and 3' neighbors, as listed in the 4x4 trinucleotide context legend. The height of each block corresponds to the mutation frequency for that kind of mutation (counts of mutations normalized by the base coverage in a given bin). The shape of the spectrum is a signature for dominant mutational mechanisms in different tumor types.
Column Descriptions:
-
nnon = number of (nonsilent) mutations in this gene across the individual set
-
npat = number of patients (individuals) with at least one nonsilent mutation
-
nsite = number of unique sites having a non-silent mutation
-
nsil = number of silent mutations in this gene across the individual set
-
p = p-value (overall)
-
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)
rank | gene | longname | codelen | nnei | nncd | nsil | nmis | nstp | nspl | nind | nnon | npat | nsite | pCV | pCL | pFN | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | APC | adenomatous polyposis coli | 8592 | 0 | 0 | 169 | 273 | 283 | 8 | 103 | 667 | 295 | 372 | 1e-16 | 1e-05 | 1 | 1e-16 | 4.6e-13 |
2 | TP53 | tumor protein p53 | 1314 | 0 | 0 | 71 | 261 | 35 | 12 | 23 | 331 | 230 | 187 | 1e-16 | 1e-05 | 1e-05 | 1e-16 | 4.6e-13 |
3 | ARID1A | AT rich interactive domain 1A (SWI-like) | 6934 | 4 | 0 | 17 | 46 | 18 | 0 | 19 | 83 | 72 | 63 | 1.2e-14 | 1e-05 | 0.087 | 1e-16 | 4.6e-13 |
4 | RNF43 | ring finger protein 43 | 2384 | 6 | 0 | 1 | 16 | 2 | 0 | 37 | 55 | 46 | 27 | 1e-16 | 1e-05 | 0.3 | 1e-16 | 4.6e-13 |
5 | SOX9 | SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) | 1538 | 1 | 0 | 0 | 7 | 5 | 1 | 27 | 40 | 36 | 37 | 1e-16 | 0.036 | 0.47 | 3.3e-16 | 1.2e-12 |
6 | MUC4 | mucin 4, cell surface associated | 3623 | 0 | 0 | 23 | 31 | 0 | 0 | 104 | 135 | 93 | 63 | 1e-16 | 1 | 0.24 | 1.2e-15 | 3.7e-12 |
7 | RBM38 | RNA binding motif protein 38 | 493 | 0 | 0 | 2 | 4 | 1 | 0 | 30 | 35 | 35 | 4 | 2.9e-16 | 1 | 0.8 | 1.1e-14 | 2.8e-11 |
8 | ACVR1B | activin A receptor, type IB | 1679 | 9 | 0 | 0 | 21 | 6 | 0 | 3 | 30 | 26 | 25 | 1.7e-11 | 0.00012 | 0.12 | 4.9e-14 | 1.1e-10 |
9 | B2M | beta-2-microglobulin | 374 | 4 | 0 | 1 | 8 | 2 | 5 | 6 | 21 | 16 | 16 | 1.6e-13 | 0.055 | 0.12 | 2.3e-13 | 4.7e-10 |
10 | TXNDC2 | thioredoxin domain-containing 2 (spermatozoa) | 1672 | 46 | 0 | 2 | 5 | 1 | 0 | 19 | 25 | 22 | 9 | 2.6e-09 | 1e-05 | 0.97 | 8.5e-13 | 1.5e-09 |
11 | SELPLG | selectin P ligand | 1217 | 20 | 0 | 1 | 5 | 0 | 0 | 12 | 17 | 16 | 9 | 1.3e-10 | 0.00011 | 0.57 | 1.3e-12 | 2.2e-09 |
12 | FAM123B | family with sequence similarity 123B | 3412 | 25 | 0 | 6 | 19 | 24 | 0 | 9 | 52 | 49 | 40 | 3e-13 | 0.14 | 0.91 | 2.1e-12 | 3.2e-09 |
13 | RBMX | RNA binding motif protein, X-linked | 1265 | 104 | 0 | 1 | 10 | 0 | 0 | 14 | 24 | 21 | 9 | 9.2e-09 | 1e-05 | 0.96 | 2.8e-12 | 4e-09 |
14 | ZFP36L2 | zinc finger protein 36, C3H type-like 2 | 1489 | 23 | 0 | 1 | 1 | 1 | 0 | 12 | 14 | 14 | 11 | 8.7e-11 | 0.0025 | 0.3 | 6.3e-12 | 8.2e-09 |
15 | BCOR | BCL6 co-repressor | 5324 | 0 | 0 | 5 | 10 | 10 | 0 | 8 | 28 | 27 | 25 | 2.2e-10 | 0.063 | 0.0028 | 9.4e-12 | 1.1e-08 |
16 | WNT1 | wingless-type MMTV integration site family, member 1 | 1125 | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 7 | 7 | 1 | 6.9e-08 | 1e-05 | 1e-05 | 2e-11 | 2.3e-08 |
17 | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 2709 | 0 | 0 | 18 | 66 | 9 | 9 | 4 | 88 | 74 | 65 | 1.7e-07 | 1e-05 | 0.3 | 4.8e-11 | 5.1e-08 |
18 | NTAN1 | N-terminal asparagine amidase | 971 | 2 | 0 | 1 | 2 | 0 | 0 | 8 | 10 | 10 | 5 | 2.5e-07 | 1e-05 | 0.99 | 6.9e-11 | 7e-08 |
19 | RHOA | ras homolog gene family, member A | 598 | 5 | 0 | 0 | 6 | 3 | 1 | 2 | 12 | 12 | 8 | 2.4e-09 | 0.0016 | 0.42 | 2.1e-10 | 2e-07 |
20 | BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 3165 | 8 | 0 | 5 | 20 | 12 | 1 | 7 | 40 | 35 | 37 | 1.1e-10 | 0.063 | 0.81 | 3e-10 | 2.7e-07 |
21 | CRIPAK | cysteine-rich PAK1 inhibitor | 1341 | 43 | 0 | 2 | 7 | 1 | 0 | 10 | 18 | 18 | 10 | 1.5e-06 | 1e-05 | 0.0082 | 3.9e-10 | 3.4e-07 |
22 | MVK | mevalonate kinase | 1235 | 18 | 0 | 2 | 5 | 0 | 1 | 10 | 16 | 15 | 7 | 4.9e-06 | 1e-05 | 0.00065 | 1.2e-09 | 1e-06 |
23 | NF2 | neurofibromin 2 (merlin) | 1894 | 0 | 0 | 24 | 51 | 14 | 10 | 1 | 76 | 62 | 59 | 8.7e-06 | 1e-05 | 0.19 | 2.1e-09 | 1.7e-06 |
24 | C15orf40 | chromosome 15 open reading frame 40 | 1036 | 4 | 0 | 2 | 2 | 0 | 0 | 8 | 10 | 10 | 3 | 6.8e-07 | 1e-05 | 1 | 2.3e-09 | 1.7e-06 |
25 | STARD3NL | STARD3 N-terminal like | 737 | 10 | 0 | 2 | 14 | 0 | 0 | 0 | 14 | 13 | 5 | 0.000011 | 2e-05 | 0.0024 | 2.7e-09 | 2e-06 |
26 | OR4D10 | olfactory receptor, family 4, subfamily D, member 10 | 936 | 91 | 0 | 2 | 15 | 0 | 0 | 0 | 15 | 14 | 9 | 0.000031 | 1e-05 | 0.02 | 7.1e-09 | 5e-06 |
27 | FMN2 | formin 2 | 5237 | 0 | 0 | 12 | 29 | 1 | 0 | 28 | 58 | 49 | 36 | 0.000032 | 1e-05 | 1 | 7.4e-09 | 5e-06 |
28 | MAPK6 | mitogen-activated protein kinase 6 | 2182 | 16 | 0 | 1 | 17 | 0 | 1 | 0 | 18 | 18 | 13 | 0.000067 | 1e-05 | 0.049 | 1.5e-08 | 9.6e-06 |
29 | NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 1380 | 2 | 0 | 3 | 9 | 0 | 0 | 6 | 15 | 15 | 10 | 4.2e-06 | 0.00017 | 0.96 | 3.1e-08 | 2e-05 |
30 | DIP2B | DIP2 disco-interacting protein 2 homolog B (Drosophila) | 4879 | 52 | 0 | 9 | 15 | 2 | 11 | 0 | 28 | 27 | 20 | 3.6e-06 | 0.00025 | 0.12 | 3.7e-08 | 0.000022 |
31 | ATXN3L | ataxin 3-like | 1068 | 17 | 0 | 1 | 16 | 1 | 0 | 1 | 18 | 17 | 14 | 0.000017 | 1e-05 | 0.3 | 3.9e-08 | 0.000023 |
32 | ALPK2 | alpha-kinase 2 | 6561 | 12 | 0 | 13 | 41 | 1 | 0 | 11 | 53 | 42 | 39 | 0.00021 | 1e-05 | 0.77 | 4.4e-08 | 0.000025 |
33 | P2RY13 | purinergic receptor P2Y, G-protein coupled, 13 | 1071 | 6 | 0 | 2 | 14 | 1 | 0 | 0 | 15 | 15 | 11 | 0.000033 | 7e-05 | 0.052 | 7.5e-08 | 0.000041 |
34 | ALG12 | asparagine-linked glycosylation 12 homolog (S. cerevisiae, alpha-1,6-mannosyltransferase) | 1503 | 0 | 0 | 0 | 2 | 0 | 0 | 5 | 7 | 7 | 5 | 0.000067 | 2e-05 | 0.95 | 8.2e-08 | 0.000043 |
35 | UBQLN2 | ubiquilin 2 | 1875 | 18 | 0 | 2 | 3 | 1 | 0 | 8 | 12 | 10 | 6 | 0.00041 | 1e-05 | 1 | 8.4e-08 | 0.000043 |
In brief, we tabulate the number of mutations and the number of covered bases for each gene. The counts are broken down by mutation context category: four context categories that are discovered by MutSig, and one for indel and 'null' mutations, which include indels, nonsense mutations, splice-site mutations, and non-stop (read-through) mutations. For each gene, we calculate the probability of seeing the observed constellation of mutations, i.e. the product P1 x P2 x ... x Pm, or a more extreme one, given the background mutation rates calculated across the dataset. [1]
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.